Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1995;91:2204-2213

This Article
Right arrow Full Text
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nunain, S. O.
Right arrow Articles by Ruskin, J. N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nunain, S. O.
Right arrow Articles by Ruskin, J. N.

(Circulation. 1995;91:2204-2213.)
© 1995 American Heart Association, Inc.


Articles

Limitations and Late Complications of Third-Generation Automatic Cardioverter-Defibrillators

S. O. Nunain, MB; M. Roelke, MD; T. Trouton, MD; S. Osswald, MD; Y. H. Kim, MD; G. Sosa-Suarez, MD; D. R. Brooks, MD; B. McGovern, MD; M. Guy, RN; D. F. Torchiana, MD; G. J. Vlahakes, MD; H. Garan, MD; J. N. Ruskin, MD

From the Cardiac Arrhythmia Service and the Cardiac Surgery Service, Harvard Medical School and the Massachusetts General Hospital, Boston.

Correspondence to Jeremy Ruskin, MD, Massachusetts General Hospital, Fruit St, Boston, MA 02114.

Background This study examines the limitations and complex management problems associated with the use of tiered-therapy, implantable cardioverter-defibrillators (ICDs).

Methods and Results The study group comprises the first 154 patients undergoing implantation of tiered-therapy ICDs at our institution. Pulse generators from three different manufacturers were used. In 39 patients, a complete nonthoracotomy lead system was used. The perioperative mortality was 1.3%. Of these 154 patients, 37% experienced late postoperative problems. Twenty-one patients required system revision within 36.5 months (mean, 8.57±11.3) of surgery. Reasons for revision were spurious shocks due to electrode fractures (3) or electrode adapter malfunction (2), inadequate signal from endocardial rate-sensing electrodes (3), superior vena cava or right ventricular coil migration (5), failure to correct tachyarrhythmias due to a postimplant rise in defibrillation threshold (5), or pulse generator failure (3). One of these patients required system removal for infection after revision of an endocardial lead. A further 32 patients received inappropriate shocks for atrial fibrillation with a rapid ventricular response or sinus tachycardia. Two of these patients also received shocks for ventricular tachycardia initiated by antitachycardia pacing triggered by atrial fibrillation. Ventricular pacing for bradycardia was associated with inappropriate shocks due to excessive autogain in 2 patients.

Conclusions Despite the major diagnostic and therapeutic advantages of tiered-therapy ICDs, a significant proportion of patients continue to experience hardware-related complications or receive inappropriate shocks.


Key Words: pacing • defibrillators • arrhythmia • defibrillation




This article has been cited by other articles:


Home page
CirculationHome page
N. Sadoul, R. Mletzko, F. Anselme, R. Bowes, W. Schols, C. Kouakam, G. Casteigneau, R. Luise, N. Iscolo, E. Aliot, et al.
Incidence and Clinical Relevance of Slow Ventricular Tachycardia in Implantable Cardioverter-Defibrillator Recipients: An International Multicenter Prospective Study
Circulation, August 16, 2005; 112(7): 946 - 953.
[Abstract] [Full Text] [PDF]


Home page
EuropaceHome page
J. C. Senges-Becker, M. Klostermann, R. Becker, A. Bauer, K. E. Siegler, H. A. Katus, and W. Schoels
What is the "Optimal" follow-up schedule for ICD patients?
Europace, January 1, 2005; 7(4): 319 - 326.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
D. A.M.J. Theuns, A. P. J. Klootwijk, D. M. Goedhart, and L. J.L.M. Jordaens
Prevention of inappropriate therapy in implantable cardioverter-defibrillators: Results of a prospective, randomized study of tachyarrhythmia detection algorithms
J. Am. Coll. Cardiol., December 21, 2004; 44(12): 2362 - 2367.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
R. Becker, J. Ruf-Richter, J. C. Senges-Becker, A. Bauer, S. Weretka, F. Voss, H. A. Katus, and W. Schoels
Patient alert in implantable cardioverter defibrillators: toy or tool?
J. Am. Coll. Cardiol., July 7, 2004; 44(1): 95 - 98.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
C A Rinaldi, R D Simon, A Baszko, J Bostock, D Elliot, C A Bucknall, and J S S Gill
A 17 year experience of inappropriate shock therapy in patients with implantable cardioverter-defibrillators: are we getting any better?
Heart, March 1, 2004; 90(3): 330 - 331.
[Full Text] [PDF]


Home page
EuropaceHome page
C. Kouakam, S. Kacet, J.-R. Hazard, A. Ferraci, H. Mansour, P. Defaye, J.-M. Davy, M. Lambiez, and on behalf of the Ventak AV Investigators
Performance of a dual-chamber implantable defibrillator algorithm for discrimination of ventricular from supraventricular tachycardia
Europace, January 1, 2004; 6(1): 32 - 42.
[Abstract] [Full Text] [PDF]


Home page
EuropaceHome page
A. Quesada, J.ús Almendral, F. Arribas, R. Ricci, C. Wolpert, P. Adragao, E. Cobo, X. Navarro, and on behalf DATAS investigators
The DATAS rationale and design: a controlled, randomized trial to assess the clinical benefit of dual chamber (DDED) defibrillator
Europace, January 1, 2004; 6(2): 142 - 150.
[Abstract] [Full Text] [PDF]


Home page
EuropaceHome page
F. A. L. E. Bracke, A. Meijer, and L. M. van Gelder
Malfunction of endocardial defibrillator leads and lead extraction: where do they meet?
Europace, January 1, 2002; 4(1): 19 - 24.
[Full Text] [PDF]


Home page
ANN INTERN MEDHome page
G. D. Sanders, M. A. Hlatky, N. R. Every, K. M. McDonald, P. A. Heidenreich, L. S. Parsons, and D. K. Owens
Potential Cost-Effectiveness of Prophylactic Use of the Implantable Cardioverter Defibrillator or Amiodarone after Myocardial Infarction
Ann Intern Med, November 20, 2001; 135(10): 870 - 883.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
G. Gronefeld and S. H Hohnloser
What do implantable cardioverter/defibrillators teach us about the mechanisms of sudden cardiac death?
Cardiovasc Res, May 1, 2001; 50(2): 232 - 241.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
M. H. Gollob and J. J. Seger
Current Status of the Implantable Cardioverter-Defibrillator
Chest, April 1, 2001; 119(4): 1210 - 1221.
[Abstract] [Full Text] [PDF]


Home page
EuropaceHome page
S. Nisam
A Prophylactic ICD? Who are the patients? What is the device?
Europace, January 1, 2001; 3(4): 269 - 274.
[PDF]


Home page
Eur Heart JHome page
T. Korte, W. Jung, G. Ostermann, C. Wolpert, S. Spehl, B. Esmailzadeh, and B. Luderitz
Hospital readmission after transvenous cardioverter/defibrillator implantation. A single centre study
Eur. Heart J., July 2, 2000; 21(14): 1186 - 1191.
[Abstract] [PDF]


Home page
ANGIOLOGYHome page
A. Oto, A. Yildirir, G. Kabakci, and E. Atalar
Inappropriate Shocks Diagnosed by Stored Electrograms of Implantable Cardioverter Defibrillators: Two Case Reports
Angiology, May 1, 2000; 51(5): 425 - 430.
[Abstract] [PDF]


Home page
EuropaceHome page
M. Greene, D. Newman, M. Geist, M. Paquette, D. Heng, and P. Dorian
Is electrical storm in ICD patients the sign of a dying heart?: Outcome of patients with clusters of ventricular tachyarrhythmias
Europace, January 1, 2000; 2(3): 263 - 269.
[Abstract] [PDF]


Home page
J Am Coll CardiolHome page
L. A. Pires, M. H. Lehmann, R. T. Steinman, J. J. Baga, C. D. Schuger, and Participating Investigators
Sudden death in implantable cardioverter-defibrillator recipients: clinical context, arrhythmic events and device responses
J. Am. Coll. Cardiol., January 1, 1999; 33(1): 24 - 32.
[Abstract] [Full Text] [PDF]


Home page
EuropaceHome page
R. Gradaus, B. Lamp, D. Hammel, M. Loick, H.H. Scheld, G. Breithardt, and M. Block
Multiple hardware complications in a patient with an ICD
Europace, January 1, 1999; 1(4): 270 - 274.
[Abstract] [PDF]


Home page
HeartHome page
D Babuty, L Fauchier, and P Cosnay
Inappropriate shocks delivered by implantable cardiac defibrillators during oversensing of activity of diaphagmatic muscle
Heart, January 1, 1999; 81(1): 94 - 96.
[Abstract] [Full Text]


Home page
J Am Coll CardiolHome page
R. Ruppel, C. A. Schluter, S. Boczor, T. Meinertz, M. Schluter, K.-H. Kuck, and R. Cappato
Ventricular tachycardia during follow-up in patients resuscitated from ventricular fibrillation: experience from stored electrograms of implantable cardioverter-defibrillators
J. Am. Coll. Cardiol., November 15, 1998; 32(6): 1724 - 1730.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
M. Rosenqvist, T. Beyer, M. Block, K. den Dulk, J. Minten, and F. Lindemans
Adverse Events With Transvenous Implantable Cardioverter-Defibrillators : A Prospective Multicenter Study
Circulation, August 18, 1998; 98(7): 663 - 670.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
F. E. Marchlinski
Predicting Arrhythmic Death : A Plea for Standardized Reporting Techniques and Data Based on Continuous Electrocardiographic Monitoring
Circulation, September 16, 1997; 96(6): 1713 - 1716.
[Full Text]


Home page
NEJMHome page
P. Spirito, C. E. Seidman, W. J. McKenna, and B. J. Maron
The Management of Hypertrophic Cardiomyopathy
N. Engl. J. Med., March 13, 1997; 336(11): 775 - 785.
[Full Text] [PDF]


Home page
CirculationHome page
M. Nair, N. Saoudi, D. Kroiss, and B. Letac
Automatic Arrhythmia Identification Using Analysis of the Atrioventricular Association: Application to a New Generation of Implantable Defibrillators
Circulation, February 18, 1997; 95(4): 967 - 973.
[Abstract] [Full Text]


Home page
CirculationHome page
G. J. Fahy, E. B. Sgarbossa, P. J. Tchou, and S. L. Pinski
Hospital Readmission in Patients Treated With Tiered-Therapy Implantable Defibrillators
Circulation, September 15, 1996; 94(6): 1350 - 1356.
[Abstract] [Full Text]


Home page
J. Thorac. Cardiovasc. Surg.Home page
T. Ferguson Jr, C. Ferguson, K Crites, and P Crimmins-Reda
THE ADDITIONAL HOSPITAL COSTS GENERATED IN THE MANAGEMENT OF COMPLICATIONS OF PACEMAKER AND DEFIBRILLATOR IMPLANTATIONS
J. Thorac. Cardiovasc. Surg., April 1, 1996; 111(4): 742 - 752.
[Abstract] [Full Text]


Home page
JWatch GeneralHome page
IMPLANTABLE DEFIBRILLATORS: PROMISE AND PROBLEMS
Journal Watch (General), April 21, 1995; 1995(421): 2 - 2.
[Full Text]